MOVE

ANALYST NOTE: MOVE (Corvex, Inc.) Date: 2026-06-13 Analyst: StoryStocks-Native Equity Research

1. Structural Readiness

Current Price: $22.53 Conservative Entry: — (Breakout not yet fired) Aggressive Entry: $14.44 (Pre-breakout / forming entry) Breakout Level: $25.68 (Resistance to clear) Extension: — Volatility Context: Current ATR is 10.4% (Extreme).

Analysis:

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None named at this date.

3. Business Analysis

Company: Corvex, Inc. (MOVE) Industry: Healthcare / Technology (Dual-Segment) Business Model: The company operates a hybrid model consisting of an AI cloud computing business and a consumer healthcare business.

AI Cloud Computing Segment: Following the acquisition of Corvex OpCo completed on March 19, 2026, the company now operates a GPU-accelerated infrastructure business.

• Revenue & Scale: In the first quarter of 2026, pro forma revenue was $3.65 million, nearly all generated from the AI platform. The acquired business contributed $475,000 in revenue and a net loss of $1.63 million for the period from March 19, 2026, to March 31, 2026.
• Capabilities: The platform provides secure, scalable, and cost-efficient computational resources, including GPU clusters, Confidential Computing, and Inference as a Service (IaaS). Management states they are investing in capabilities to support deployments ranging from 2,000 GPUs to hyperscale clusters exceeding 100,000 GPUs.
• Customer Base: Primary customers include AI model labs, hyperscalers, government-backed AI initiatives, and enterprises. Technology companies represent a significant portion of the base, utilizing the clusters for training and deploying generative AI models.
• Pipeline & Capacity: As of March 31, 2026, the company held $3.4 million in prepaid expenses and other current assets specifically for advance payments for server purchases. Management expects to add data center capacity in domestic and foreign geographies based on customer demand.
• Sales Strategy: The company focuses on annual or multi-year commitments to ensure performance and security.

Healthcare Segment:

• Product: The "Wellness Ring" (formerly Evie Ring), a wearable designed for women.
• Regulatory Status: Received FDA 510(k) clearance for the pulse oximetry feature in November 2024, classifying it as a medical device.
• Financial Impact: The acquired business (Corvex OpCo) was the primary revenue driver in the recent quarter; the healthcare segment's specific revenue contribution for the March 2026 quarter is not explicitly broken out in the provided evidence, though the company notes the ring was launched in November 2023.

Management Expectations (Source: Earnings Transcript 2026-05-22): Management expects AI to drive a "once-in-a-generation transformation" in global computing infrastructure. They anticipate accelerating demand for secure, scalable, high-performance AI infrastructure as models become larger and more integrated into enterprise workflows. They plan to expand sales infrastructure by hiring additional sales, technical, and marketing personnel to enhance pipeline visibility.

4. Archetype and Conviction

Archetype: Quality Compounder (Candidate) Valuation Context:

• Forward Consensus EPS (FY1): -10.68 (Financial Spine coverage complete).
• Profitability: The company is currently unprofitable on an adjusted basis. Adjusted pro forma EBITDA for the March quarter was a loss of $933,000.
• Dilution Risk: As of March 31, 2026, unamortized compensation expense related to unvested stock options was approximately $77.5 million, expected to be recognized over a weighted average period of 3.95 years.

Conviction Stack:

• Thesis Strength: Low (Tactical only; no named secular thesis).
• Evidence Quality: High. Recent earnings (May 22, 2026) and SEC filings (May 19, 2026) provide granular data on the post-acquisition integration, revenue mix, and capex commitments ($3.4M in server prepayments).
• Setup Readiness: Partial. The 69% historical breakout rate for forming coils suggests a favorable probability, but the setup is not yet confirmed.
• Rerating Potential: High, contingent on the successful scaling of the AI infrastructure business and the ability to convert the $3.4M in prepayments into billable capacity.

Summary: The name fits the "Quality Compounder" archetype in terms of its strategic positioning in the AI infrastructure space and its dual-segment approach, but the financials (negative EPS, high dilution, EBITDA loss) and extreme volatility currently weigh against a high-conviction rating. The setup is the primary driver of the thesis.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

• Fundamental: Failure to deploy the $3.4 million in prepaid server assets into revenue-generating clusters, or a significant slowdown in customer acquisition for the AI segment.

What Would Strengthen the Case:

• Technical: A confirmed breakout and close above $25.68 with volume expansion.
• Fundamental: Evidence of multi-year contract renewals or expansion of the customer base beyond the initial hyperscalers, or a reduction in the adjusted EBITDA loss in the subsequent quarter.

Gaps in Evidence:

• Healthcare Revenue Specifics: While the Wellness Ring is mentioned, the specific revenue contribution of the healthcare segment in the March 2026 quarter is not explicitly detailed in the provided evidence, making it difficult to assess the standalone health of that division.
• Cash Runway: While prepaid assets are noted, the total cash balance and burn rate post-acquisition are not explicitly quantified in the provided snippets, creating a gap in assessing liquidity risk given the $77.5M in unvested comp and negative EBITDA.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key risks: Extreme ATR of 10.4% indicating high volatility and potential for false breakouts; Forward consensus EPS of -10.68 and $77.5M in unvested stock comp creating significant dilution and loss risk; Lack of named secular thesis limiting conviction. Sizing hint: Position size must be reduced significantly to account for the extreme ATR and the unconfirmed nature of the forming coil. Expected path: Price consolidates near current levels while management executes on server deployment; a breakout above $25.68 would confirm the setup and potentially trigger a re-rating if revenue growth accelerates. Expected horizon: 3 to 6 months for the breakout or invalidation to resolve. Failure mode to watch: A daily close below $12.38, which would invalidate the entire coil structure and signal a breakdown in market support.